FindTrial
Sign In

Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (COMPASS) - Efficacy of a pre-operative clinical framework: a retrospective Analysis Based on Patient Records

Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (COMPASS) - Efficacy of a pre-operative clinical framework

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018108
Enrollment
Unknown
Registered
2018-08-31
Start date
2017-10-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid microcarcinoma

Interventions

Case series:Not applicable

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Neck/ultrasonography suggest to be suspicious PTMC. (whether have Fine-needle aspiration examination); 2. Postoperative pathological result diagnosed as a PTMC patient. (Study time is from 01 Oct 2017 to 31 Oct 2018.

Exclusion criteria

Exclusion criteria: 1. Preoperative neck/ultrasonography diagnosed as Benign thyroid nodules,but examined PTMC after the operation; 2. Had thyroid operation history; 3. Associated with other malignancies; 4. Age less than 14 years old; 5. Information related to the patients research endpoint was missing (research endpoint information includes preoperative Neck/ultrasonography, preoperative TSH level, operation records, postoperative pathology).

Design outcomes

Primary

MeasureTime frame
preoperative Neck/ultrasonography;postoperative pathology;—

Secondary

MeasureTime frame
TSH level;—

Countries

China

Contacts

Public ContactZhuoying Wang

Fudan University Shanghai Cancer Center

zhuoyingwang@hotmail.com+86 13601756709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026